Finance

The newly spun-off GE HealthCare entered into an agreement to acquire IMACTIS, developer of CT interventional guidance technology.

The U.K.-based company will form an advanced clinical trials division offering digital health solutions for each phase of the development process.

The company let go of over 200 people in its second round of layoffs in the past year and plans to shift its focus to its primary care and urgent care services.

The home diagnostics company also cut 170 manufacturing jobs in the summer.

GE HealthCare began trading on Nasdaq as an independent company on Wednesday.

The Oregon Health Authority said the deal is not likely to greatly reduce access to affordable care in the state, but it placed some conditions on its approval.

Adam Wolfberg, chief medical officer at Current Health, explains how the company fits into Best Buy Health's strategy and where the focus lies in the new year.

Although investment slowed for startups, leaders noted several big deals in digital health, particularly among retail players.

Drug development platform Quris raised another $9 million, and PharmStars is accepting applications for its accelerator cohort focused on women's health and health equity.

The U.S. International Trade Commission determined Apple Watches with ECG functionality violate AliveCor patents, but an import ban is on hold until appeals wrap up in a case before the U.S. Patent and Trademark Office's Patent Trial and Appeal Board.